Classical Hodgkin Lymphoma Latest Advances

Find the Latest Research About Classical Hodgkin Lymphoma

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1142 publications

American Society of Transplantation and Cellular Therapy Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma.

American Society of Transplantation and Cellular Therapy Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma.

Journal: Transplantation and cellular therapy
Published: December 09, 2025

Expression of sialylated CD15 in classical Hodgkin lymphoma following sialidase digestion

Expression of sialylated CD15 in classical Hodgkin lymphoma following sialidase digestion

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: December 08, 2025

Cholestatic Jaundice as the Initial Manifestation of Classical Hodgkin Lymphoma: A Diagnostic Challenge.

Cholestatic Jaundice as the Initial Manifestation of Classical Hodgkin Lymphoma: A Diagnostic Challenge.

Journal: Cureus
Published: November 19, 2025

Beyond PD-1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next-Generation Immune Strategies.

Beyond PD-1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next-Generation Immune Strategies.

Journal: European journal of haematology
Published: November 17, 2025

Nivolumab with doxorubicin, vinblastine, and dacarbazine for the frontline treatment of central nervous system classical Hodgkin lymphoma.

Nivolumab with doxorubicin, vinblastine, and dacarbazine for the frontline treatment of central nervous system classical Hodgkin lymphoma.

Journal: Leukemia & lymphoma
Published: October 31, 2025

Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era.

Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era.

Journal: Oncology (Williston Park, N.Y.)
Published: October 31, 2025

Advanced Classical Hodgkin Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group.

Advanced Classical Hodgkin Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group.

Journal: JCO global oncology
Published: October 29, 2025

Soluble cytokines enhance risk prediction across all stages of classical Hodgkin lymphoma.

Soluble cytokines enhance risk prediction across all stages of classical Hodgkin lymphoma.

Journal: Biomarker research
Published: October 17, 2025

Improved therapies, incomplete data: late toxicity after modern classical Hodgkin Lymphoma radiotherapy.

Improved therapies, incomplete data: late toxicity after modern classical Hodgkin Lymphoma radiotherapy.

Journal: Acta oncologica (Stockholm, Sweden)
Published: October 15, 2025

Surprising diagnosis: classical Hodgkin lymphoma presenting as an acute asthma attack.

Surprising diagnosis: classical Hodgkin lymphoma presenting as an acute asthma attack.

Journal: BMJ case reports
Published: October 14, 2025

Treatment strategy for classical Hodgkin lymphoma and future perspectives

Treatment strategy for classical Hodgkin lymphoma and future perspectives

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025

Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers.

Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers.

Journal: European journal of haematology
Published: September 29, 2025
Showing 1-12 of 1,142

Last Updated: 02/24/2026